Hisashi Yokomizo

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 6

Top Venues

Diabetes, obesity & metabolism

The Biochemical journal

Circulation research

Nature communications

Joslin Diabetes Center

Joslin Diabetes Center (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Joslin Diabetes Center

United States

MD, PhD

Education History

Joslin Diabetes Center

United States

PHD

Publications

null null, Shunichiro Tsukamoto, Kazuo Kobayashi, Masao Toyoda, Atsuhito Tone, Daiji Kawanami, Daisuke Suzuki, Daisuke Tsuriya, Hideo Machimura, Hidetoshi Shimura, Hiromichi Wakui, Hiroshi Takeda, Hisashi Yokomizo, Kei Takeshita, Keiichi Chin, Keizo Kanasaki, Masaaki Miyauchi, Masuo Saburi, Miwa Morita, Miwako Yomota, Moritsugu Kimura, Nobuo Hatori, Shinichi Nakajima, Shun Ito, Takashi Murata, Takaya Matsushita, Takayuki Furuki, Takuya Hashimoto, Tomoya Umezono, Yoshimi Muta, Yuichi Takashi, Kouichi Tamura
Effect of preceding drug therapy on the renal and cardiovascular outcomes of combined sodium-glucose cotransporter-2 inhibitor and glucagon-like peptide-1 receptor agonist treatment in patients with type 2 diabetes and chronic kidney disease. Diabetes, obesity & metabolism 26 (8) (2024)
null null, Shunichiro Tsukamoto, Kazuo Kobayashi, Masao Toyoda, Atsuhito Tone, Daiji Kawanami, Daisuke Suzuki, Daisuke Tsuriya, Hideo Machimura, Hidetoshi Shimura, Hiromichi Wakui, Hiroshi Takeda, Hisashi Yokomizo, Kei Takeshita, Keiichi Chin, Keizo Kanasaki, Masaaki Miyauchi, Masuo Saburi, Miwa Morita, Miwako Yomota, Moritsugu Kimura, Nobuo Hatori, Shinichi Nakajima, Shun Ito, Takashi Murata, Takaya Matsushita, Takayuki Furuki, Takuya Hashimoto, Tomoya Umezono, Yoshimi Muta, Yuichi Takashi, Kouichi Tamura
Effect of preceding drug therapy on the renal and cardiovascular outcomes of combined sodium-glucose cotransporter-2 inhibitor and glucagon-like peptide-1 receptor agonist treatment in patients with type 2 diabetes and chronic kidney disease. Diabetes, obesity & metabolism (2024)
Kyoungmin Park, Qian Li, Matthew D Lynes, Hisashi Yokomizo, Ernesto Maddaloni, Takanori Shinjo, Ronald St-Louis, Qin Li, Sayaka Katagiri, Jialin Fu, Allen Clermont, Hyunseok Park, I-Hsien Wu, Marc Gregory Y Yu, Hetal S Shah, Yu-Hua Tseng, George Liang King
Endothelial Cells Induced Progenitors Into Brown Fat to Reduce Atherosclerosis. Circulation research 131 (2) (2022)
Hiroko Otsuka, Hisashi Yokomizo, Shintaro Nakamura, Yoshihiro Izumi, Masatomo Takahashi, Sachiko Obara, Motonao Nakao, Yosuke Ikeda, Naoichi Sato, Ryuichi Sakamoto, Yasutaka Miyachi, Takashi Miyazawa, Takeshi Bamba, Yoshihiro Ogawa
Differential effect of canagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, on slow and fast skeletal muscles from nondiabetic mice. The Biochemical journal 479 (3) (2022)
Hisashi Yokomizo, Yasutaka Maeda, Kyoungmin Park, Allen C Clermont, Sonia L Hernandez, Ward Fickweiler, Qian Li, Chih-Hao Wang, Samantha M Paniagua, Fabricio Simao, Atsushi Ishikado, Bei Sun, I-Hsien Wu, Sayaka Katagiri, David M Pober, Liane J Tinsley, Robert L Avery, Edward P Feener, Timothy S Kern, Hillary A Keenan, Lloyd Paul Aiello, Jennifer K Sun, George Liang King
Retinol binding protein 3 is increased in the retina of patients with diabetes resistant to diabetic retinopathy. Science translational medicine 11 (499) (2020)
Qian Li, Jialin Fu, Yu Xia, Weier Qi, Atsushi Ishikado, Kyoungmin Park, Hisashi Yokomizo, Qian Huang, Weikang Cai, Christian Rask-Madsen, C Ronald Kahn, George L King
Homozygous receptors for insulin and not IGF-1 accelerate intimal hyperplasia in insulin resistance and diabetes. Nature communications 10 (1) (2019)

Hisashi Yokomizo.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Hisashi Yokomizo